NCT03490604View on ClinicalTrials.gov

Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Unresectable Pancreatic Adenocarcinoma
Interventions
DEVICE

wrist-worn accelerometer

accelerometer worn on the patient's wrist, changed every 15 ± 7 days for 6 months when the patient comes for a chemotherapy session

OTHER

Auto-questionnaires

Questionnaire regarding physical activity over the previous 7 days, questionnaires EORTC QLQ-C30 and EORTC QLQ-PAN26

Trial Locations (1)

21000

Chu Dijon Bourogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT03490604 - Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients | Biotech Hunter | Biotech Hunter